Impax to market generic Doryx
Impax Laboratories Inc. has received final approval from the Food and Drug Administration for 75-mg and 100-mg doxycyline hyclate delayed-release tablets, a generic version of the antibacterial medication Doryx.
Supplier News
Half of Frito-Lay product lineup to be all-natural
Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers. The PepsiCo division said Tuesday that the strategy includes three of its biggest brands: Lay’s, Tostitos and SunChips.
Coty readies flurry of Sally Hansen launches
Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum. The company is also rolling out new Sally Hansen hand creams, foot care products, lip treatments and a depilatory.
Sustainability strategy progresses at Nice-Pak
Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility. The move, expected to keep more than 4,200 tons of waste a year from going into landfills, is the second transformation of a Nice-Pak facility in the past six months.
Cephalon names Buchi as CEO
Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company’s board. The move comes following the death of Cephalon founder, chairman and CEO Frank Baldino Jr. earlier this month at age 57 from complications related to leukemia.
Merck’s Gardasil approved for new indications
Gardasil, Merck’s vaccine for human papillomavirus (HPV), has been approved by the Food and Drug Administration for the prevention of anal cancer and anal intraepithelial neoplasia (AIN).
Watson gets OK for novel oral contraceptive
Watson Pharmaceuticals next year plans to roll out a chewable, low-dose oral contraceptive that the company called a new option for birth control.
Novartis triple-combination pill approved for hypertension
Novartis has received approval from the Food and Drug Administration for Amturnide tablets for the treatment of high blood pressure.
PhRMA elects new board members
The Pharmaceutical Research and Manufacturers of America (PhRMA) this week announced the election of four new members to its board of directors. PhRMA said Tuesday that the new board members are Ian Read, president and chief executive officer of Pfizer Inc.; Jerzy Gruhn, president Novo Nordisk Inc.
Abbott Diabetes Care recalls blood glucose test strips
Abbott Diabetes Care has begun a recall of 359 lots of various brands of blood glucose test strips in the United States and Puerto Rico.
Olay professional facial cleansing system makes debut
Olay has introduced the Olay Professional Pro-X Advanced Cleansing System, which the Procter & Gamble Co. skin care brand said is first at-home facial cleansing tool that cleans and exfoliates as effectively as a professional cleansing system.
Lily Endowment helps fund new pharmacy school
Manchester College in northern Indiana has received a $35 million grant from Lilly Endowment to launch a school of pharmacy.
Novo Nordisk, Emisphere partner on oral insulin
Emisphere Technologies Inc. and Novo Nordisk A/S have teamed up to develop oral formulations of insulin for diabetes.
Amneal adds Quinnova Pharmaceuticals to alliance
Amneal Enterprises LLC has expanded into the dermatology market with the addition of Quinnova Pharmaceuticals Inc. as an independent affiliate. Newtown, Pa.-based Quinnova joins the Amneal alliance of life science companies through its acquisition by AmDerma Pharmaceuticals LLC, Amneal said Monday.
Tom’s of Maine program helps mobile dental clinics
Tom’s of Maine is encouraging mobile dental clinics nationwide to apply for $20,000 in program funding as part of its annual Dental Health For All program.
Prestige Brands to buy Dramamine from McNeil
Prestige Brands Holdings Inc. has entered into an agreement to acquire the assets associated with the Dramamine business in the United States from McNeil-PPC Inc. for $76 million.